Home / Pharmaceutical company intelligence
Atco Laboratories Limited logo
Pharmaceutical company intelligence

Atco Laboratories Limited

Pharmaceutical manufacturer · Karachi · Pakistan

Long-established Pakistan pharmaceutical manufacturer developing, formulating and marketing generic medicines from a cGMP-compliant Karachi facility.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation23 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date27 Jul 2026Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Company type
Pharmaceutical manufacturer
Address
B-18, S.I.T.E., Karachi-75700, Pakistan · 75700
Phone
+92 21 111 111 645
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
100%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000188 Atco Laboratories Limited · Sindh
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000188 268 linked products · source seen 23 Sep 2026 View source ↗
DSL 025 10 linked products · source seen 23 Sep 2026 View source ↗
Corporate profile source ledger Logo Url source ↗ Contact Page Url source ↗ Logo Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx278public portfolio records represented
REG183unique registrations represented
IDX92indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+0registry-only registrations
VER0registry-verified exact registrations
PKR265current validated price records
G94generic molecules in indexed catalogue
DF15dosage-form groups
TA15therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage95%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage86%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixAtco Laboratories LimitedShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/atco-laboratories-limitedGenerated 23 Sep 2026Anti-infectives94 · 34%Cardiovascular51 · 18%Endocrine & metabolic33 · 12%Hematology & thrombosis29 · 10%Dermatology17 · 6%Pain & musculoskeletal12 · 4%CNS & mental health12 · 4%Other therapeutic areas30 · 11%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioAtco Laboratories LimitedDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/atco-laboratories-limitedGenerated 23 Sep 2026278presentationsTablet162 · 58%Injection25 · 9%Suspension23 · 8%Cream20 · 7%Capsule14 · 5%Solution10 · 4%Other forms24 · 9%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionAtco Laboratories LimitedCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/atco-laboratories-limitedGenerated 23 Sep 2026240comparable productsBelow peer median89 · 37%Near peer median64 · 27%Above peer median87 · 36%Company median price position+0.0%Lowest-price equivalents39Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsAtco Laboratories LimitedCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/atco-laboratories-limitedGenerated 23 Sep 2026Nabiqasim Industries (Pvt) Ltd.,50 shared53% overlapValor Pharmaceuticals44 shared47% overlapCCL Pharmaceuticals (Pvt.) Limited39 shared41% overlapTABROS PHARMA (PVT). LTD.39 shared41% overlapZafa Pharmaceutical Laboratories (P…38 shared40% overlapM/s. Genix Pharma (Pvt) Ltd.37 shared39% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives94 products · 34%
Cardiovascular51 products · 18%
Endocrine & metabolic33 products · 12%
Hematology & thrombosis29 products · 10%
Dermatology17 products · 6%
Pain & musculoskeletal12 products · 4%
CNS & mental health12 products · 4%
Oncology & immunology11 products · 4%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Antidiabetic medicines33 products · 12%
Antifungals18 products · 6%
Anticoagulants17 products · 6%
Calcium-channel blockers14 products · 5%
Antivirals13 products · 5%
Angiotensin receptor blockers13 products · 5%
Fluoroquinolone antibacterials11 products · 4%
Topical corticosteroids / anti-inflammatory dermatologics11 products · 4%
Formulation footprint

Dosage forms

Tablet162 products
Injection25 products
Suspension23 products
Cream20 products
Capsule14 products
Solution10 products
Ointment7 products
Drops4 products
Gel4 products
Lotion3 products
Sachet2 products
Inhalation1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 Adrance-MEmpagliflozin + Metformin 19presentations 12.5 mg + 1000 mg, 12.5 mg + 500 mg, 12.5 mg + 850 mg, 5 mg + 1000 mg · Tablet #2 REVOBANRivaroxaban 11presentations 10 mg, 15 mg, 2.5 mg, 20 mg · Tablet #3 ADRANCEEmpagliflozin 10presentations 10 mg, 25 mg · Tablet #4 Tiocardis-AMTelmisartan + Amlodipine 9presentations 40 mg + 10 mg, 40 mg + 5 mg, 80 mg + 10 mg, 80 mg + 5 mg · Tablet #5 ASCARDAcetylsalicylic acid (Aspirin) 8presentations 100 mg, 150 mg, 300 mg, 75 mg · Tablet #6 BISOPROLOLBisoprolol fumarate 8presentations 10 mg, 2.5 mg, 5 mg · Tablet
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median8937% of comparable products
Near market median64within ±5% of median
Above market median8736% of comparable products
Lowest-price equivalents39ties included
Company median price position +0.0% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
SULFAZINE 1%Silver sulfadiazine · Cream · 500g PKR 1.55/g-72.0% vs market median Primox DS 800 mg + 160 mgSulfamethoxazole + Trimethoprim · Tablet · 100's PKR 2.91/tablet-68.5% vs market median Rumafen 200 mgIbuprofen · Tablet · 500's PKR 0.81/tablet-64.9% vs market median SULFAZINE 1 %Silver sulfadiazine · Cream · 250g PKR 1.55/g-59.3% vs market median Rumafen 200 mgIbuprofen · Tablet · 30's PKR 1.00/tablet-56.7% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Nabiqasim Industries (Pvt) Ltd.,365 products · 118 generics 50shared generics Valor Pharmaceuticals219 products · 97 generics 44shared generics CCL Pharmaceuticals (Pvt.) Limited249 products · 99 generics 39shared generics TABROS PHARMA (PVT). LTD.179 products · 65 generics 39shared generics Zafa Pharmaceutical Laboratories (Pvt) Ltd.245 products · 97 generics 38shared generics M/s. Genix Pharma (Pvt) Ltd.297 products · 97 generics 37shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers183Distinct registrations among indexed, published, presentation-validated products only
Verified price observations279
Products with a verified price278
Products with multiple price observations1
Source records with multiple versions275
Latest portfolio source check22 Sep 2026
Latest effective price date27 Jul 2026
Latest source observation23 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

183 unique registration(s) · 92 indexed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Intelligence filter: Therapeutic areaAnti-infectives Clear intelligence filters
Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
A-FANTRINE Artemether + Lumefantrine 20 mg + 120 mg Tablet 2 x 8's 047214 PKR 590.91 PKR 36.93/tablet 7% below median
A-FANTRINE Artemether + Lumefantrine 40 mg + 240 mg Tablet 8's 053368 PKR 556.65 PKR 69.58/tablet 9% above median
A-FANTRINE Artemether 80 mg Injection 1ml x 5's 073870 PKR 991.35 PKR 198.27/mL 12% above median
A-FANTRINE Artemether 40 mg Injection 1ml x 10's 073871 PKR 1,107.95 PKR 110.80/mL 12% below median
A-FANTRINE BD Artemether + Lumefantrine 80 mg + 480 mg Tablet 6's 058434 PKR 695.80 PKR 115.97/tablet 6% above median
A-FANTRINE BD Artemether + Lumefantrine 80 mg + 480 mg Tablet 4's 058434 PKR 406.24 PKR 101.56/tablet 7% below median
ATCOFLOX Levofloxacin 250 mg Tablet 10's 045219 PKR 516.32 PKR 51.63/tablet 8% above median
ATCOFLOX Levofloxacin 500 mg Tablet 10's 045220 PKR 847.06 PKR 84.71/tablet 7% above median
ATCOFLOX Levofloxacin 750 mg Tablet 10's 050743 PKR 923.30 PKR 92.33/tablet Near median
ATCOVIR + Lopinavir + Ritonavir 200 mg + 50 mg Tablet 120's 104143 PKR 11,525.21 PKR 96.04/tablet Near median
AVOTREXID Linezolid 600 mg Tablet 12's 044404 PKR 5,351.95 PKR 446.00/tablet 13% above median
AVOTREXID Linezolid 100 mg/5 mL Dry suspension 60ml 090792 PKR 646.31 PKR 10.77/mL Near median
AVOTREXID Linezolid 100 mg/5 mL Dry suspension 120ml 090792 PKR 1,227.98 PKR 10.23/mL 5% below median
AVOTREXID Linezolid 400 mg Tablet 12's 097145 PKR 2,696.01 PKR 224.67/tablet Near median
AZATCO Azithromycin 500 mg Tablet 6's 104138 PKR 412.68 PKR 68.78/tablet 19% below median
AZATCO Azithromycin 250 mg Tablet 6's 104139 PKR 225.10 PKR 37.52/tablet 20% below median
AZATCO Azithromycin 200 mg/5 mL Oral suspension 15 mL 104140 PKR 247.62 PKR 16.51/mL 18% below median
AZATCO Azithromycin 100 mg/5 mL Oral suspension 30 mL 104141 PKR 150.07 PKR 5.00/mL 11% below median
AZATCO Azithromycin 250 mg Capsule 6's 104142 PKR 229.61 PKR 38.27/capsule 23% below median
AZATCO Azithromycin 250 mg Capsule 10's 104142 PKR 382.68 PKR 38.27/capsule 23% below median
C-OFF Sofosbuvir 400 mg Tablet 28's 083008 PKR 11,948.35 PKR 426.73/tablet Near median
CLOROXIL Clotrimazole 1% Cream 15g 096199 PKR 84.94 PKR 5.66/g Near median
CLOROXIL W/W Clotrimazole 1 % Cream 10g 096199 PKR 59.10 PKR 5.91/g 7% below median
CUREZOLE Clotrimazole + Hydrocortisone 10 mg/g + 10 mg/g Cream 30GM 081006 PKR 302.18 PKR 10.07/g 12% below median
Curezole Clotrimazole + Hydrocortisone 10 mg + 10 mg Cream 15GM 081006 PKR 173.98 PKR 11.60/g Near median
Curezole Clotrimazole + Hydrocortisone 10 mg/g + 10 mg/g Cream 10GM 081006 PKR 114.19 PKR 11.42/g 5% above median
D-HEP Daclatasvir 30 mg Tablet 28s 086670 PKR 5,401.26 PKR 192.90/tablet Near median
D-HEP Daclatasvir 60 mg Tablet 28s 086671 PKR 8,837.71 PKR 315.63/tablet Near median
DIAZOL Metronidazole (Benzoate) 320 mg/5 mL Suspension 60ml 007792 PKR 29.53 PKR 0.49/mL 70% below median
Doxyn Doxycycline 100 mg Capsule 50's 005999 PKR 571.06 PKR 11.42/capsule 46% above median
Doxyn Doxycycline 100 mg Capsule 1's 005999 PKR 10.21 PKR 10.21/capsule 30% above median
Doxyn Doxycycline 50 mg Tablet 5x10's 029872 PKR 184.03 PKR 3.68/tablet No comparator
EYFOREX Ofloxacin 3 mg/mL Ophthalmic drops 5ml 037481 PKR 147.73 PKR 29.55/mL Near median
Fixicef Cefixime 400 mg Capsule 1 x 5's Blister 080271 PKR 592.04 PKR 118.41/capsule Near median
FIXICEF Cefixime 100 mg/5 mL Oral suspension 30ml 080273 PKR 330.39 PKR 11.01/mL 8% above median
Fixicef Cefixime 200 mg Tablet 5s 086656 PKR 320.35 PKR 64.07/tablet Near median
Fixicef Cefixime 200 mg Tablet 10s 086656 PKR 609.63 PKR 60.96/tablet 6% below median
FIXICEF DS Cefixime 200 mg/5 mL Oral suspension 30ml 080272 PKR 412.78 PKR 13.76/mL Near median
Fonaz Fluconazole 150 mg Tablet 1's 088222 PKR 178.38 PKR 178.38/tablet 6% below median
Fonaz Fluconazole 50 mg Capsule 7's 088223 PKR 873.68 PKR 124.81/capsule Near median
Fonaz Fluconazole 200 mg Capsule 4's 088224 PKR 931.92 PKR 232.98/capsule 5% above median
Fonaz Fluconazole 50 mg/5 mL Oral suspension 35 ml 088225 PKR 407.71 PKR 11.65/mL No comparator
Fonaz Fluconazole 150 mg Capsule 1's 089341 PKR 273.52 PKR 273.52/capsule Near median
GENOVIREX Entecavir 0.5 mg Tablet 30's 061765 PKR 18,835.17 PKR 627.84/tablet 76% above median
GENOVIREX Entecavir 1 mg Tablet 30's 061766 PKR 31,391.95 PKR 1,046.40/tablet 81% above median
GENOVIREX Entecavir 0.05 mg/mL Oral solution 120ml 061767 PKR 4,801.12 PKR 40.01/mL 7% below median
Gentacil Gentamicin 0.3 % Ear drops 7.5ml 013895 PKR 26.85 PKR 3.58/mL 24% below median
Gentacil Gentamicin 40 mg/mL Injection 3's x 1 ml 013959 PKR 60.01 PKR 20.00/mL 21% below median
Gentacil Gentamicin 80 mg/2 mL Injection 10's x 2ml 015835 PKR 437.36 PKR 21.87/mL 40% above median
IVERMITE Ivermectin 6 mg Tablet 10'S 061339 PKR 595.62 PKR 59.56/tablet 9% above median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Atco Laboratories Limited — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/company/atco-laboratories-limited/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.